Come up with a name for your new list and we'll add to it:
TearClear raised a round of funding on February 14, 2019. Investors include
Bluestem Capital Partners.
TearClear is an early-stage medical science company that is launching a proprietary chemical filter designed to safely deliver ophthalmic topical solutions. The company aims to assure long-term eye he…